|
Market Cap (1-Jul) $29,825,232,896 (100th) |
Close (30-Jun) $65.64 |
Volume (30-Jun) 149,294 |
Shortsold (19-Jun) 1,305,476 (1.25%) (181st) |
|
52w High $298.71 |
52w Low $120.92 |
P/E 166.67 |
EPS 0.93 |
PME released this announcement to the ASX on 2 February 2021, 10:13. The announcement is marked as price sensitive, and is 2 page(s) in length and 108.7kb in size.
You can view all announcements from PME and see how they appear on a price chart on the announcements page.
At the date of this announcement, PME was 4.433% short sold according to ASIC data. It was ranked the 31st most shorted stock on the ASX. It remains ranked 181st as of the latest reported data (19 June 2025).
| Other Recent Announcements from PME | |
|---|---|
| PME signs 7-year, $20M contract with Gundersen Health System | 16 May 2023, 9:12 |
| Notification of buy-back - PME | 3 April 2023, 8:59 |
| Update - Notification of buy-back - PME | 31 March 2023, 9:47 |
| PME receives FDA approval for Breast Density Algorithm | 2 February 2021, 10:13 |
| CEO Interview - Intermountain deal | 14 January 2021, 10:37 |
| PME signs A$40M - 7 year contract with Intermountain Health | 14 January 2021, 8:57 |
| CEO Interview Medstar deal and single vendor solution | 17 December 2020, 11:19 |
You must be logged in to post a reply.
Pro Medicus 